Trials / Completed
CompletedNCT01078233
Observational Data Analysis in EuroSIDA (MK-0518-058)
Observational Safety Data Analysis From Routine Follow-up in the EuroSIDA Study of Patients Treated With Raltegravir in a Five-Year Post Authorization Period
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,617 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to monitor health outcomes associated with antiretroviral drugs in a population of HIV-infected patients.
Detailed description
Time Perspective: Retrospective and Prospective
Conditions
Timeline
- Start date
- 2008-05-05
- Primary completion
- 2014-03-06
- Completion
- 2014-03-06
- First posted
- 2010-03-02
- Last updated
- 2019-11-25
- Results posted
- 2015-09-17
Source: ClinicalTrials.gov record NCT01078233. Inclusion in this directory is not an endorsement.